§ 1.710. Patents subject to extension of the patent term.
238 words·~1 min read·
/us/cfr/t37/s§ 1.710·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)A patent is eligible for extension of the patent term if the patent claims a product as defined in paragraph
(b)of this section, either alone or in combination with other ingredients that read on a composition that received permission for commercial marketing or use, or a method of using such a product, or a method of manufacturing such a product, and meets all other conditions and requirements of this subpart.
(b)The term product referred to in paragraph
(a)of this section means---
(1)The active ingredient of a new human drug, antibiotic drug, or human biological product (as those terms are used in the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act) including any salt or ester of the active ingredient, as a single entity or in combination with another active ingredient; or
(2)The active ingredient of a new animal drug or veterinary biological product (as those terms are used in the Federal Food, Drug, and Cosmetic Act and the Virus-Serum-Toxin Act) that is not primarily manufactured using recombinant DNA, recombinant RNA, hybridoma technology, or other processes including site specific genetic manipulation techniques, including any salt or ester of the active ingredient, as a single entity or in combination with another active ingredient; or
(3)Any medical device, food additive, or color additive subject to regulation under the Federal Food, Drug, and Cosmetic Act. \[54 FR 30379, July 20, 1989\]
Connections6 cite this
Citation graph
cites case law
§ 1.710
Patents subject to extension of the patent term.
Fed. Reg.×6
Cites 0Cited by 6 across 1 source